1. Identification of a seven-miRNA signature as prognostic biomarker for lung squamous cell carcinoma
   Xujie Gao et al, 2016, Oncotarget CrossRef
2. Inhibition of miR‐24 suppresses malignancy of human non‐small cell lung cancer cells by targeting WWOX in vitro and in vivo
   Xue‐hai Wang et al, 2018, Thoracic Cancer CrossRef
3. Long non-coding RNA LINC01270 is an onco-promotor in lung adenocarcinoma by upregulating LARP1 via sponging miR-326
   Weiran Zhang et al, 2022, Bioengineered CrossRef
4. New and Old Genes Associated with Primary and Established Responses to Paclitaxel Treatment in Ovarian Cancer Cell Lines
   Monika Świerczewska et al, 2018, Molecules CrossRef
5. The MicroRNA‐326: Autoimmune diseases, diagnostic biomarker, and therapeutic target
   Golamreza Jadideslam et al, 2018, Journal of Cellular Physiology CrossRef
6. Immunomodulatory functions of the circ_001678/miRNA-326/ZEB1 axis in non-small cell lung cancer via the regulation of PD-1/PD-L1 pathway
   Qi Tian et al, 2022, Human Molecular Genetics CrossRef
7. MiR‐326/Sp1/KLF3: A novel regulatory axis in lung cancer progression
   Rong Wang et al, 2019, Cell Proliferation CrossRef
8. MicroRNA-326 inhibits cell proliferation and invasion, activating apoptosis in hepatocellular carcinoma by directly targeting LIM and SH3 protein 1
   Shiping Hu et al, 2017, Oncology Reports CrossRef
9. MiR-326 antagomir delays the progression of age-related cataract by upregulating FGF1-mediated expression of betaB2-crystallin
   Hanxiao Ren et al, 2018, Biochemical and Biophysical Research Communications CrossRef
10. MicroRNA‐326 negatively regulates CD155 expression in lung adenocarcinoma
    Takayuki Nakanishi et al, 2023, Cancer Science CrossRef
11. Screening and bioinformatics analysis of a ceRNA network based on the circular RNAs, miRNAs, and mRNAs in pan‐cancer
    Zhanghan Chen et al, 2020, Cancer Medicine CrossRef
12. hsa_circ_0139402 Promotes Bladder Cancer Progression by Regulating hsa-miR-326/PAX8 Signaling
    Bo Wei et al, 2022, Disease Markers CrossRef
13. Circulating miR-326 could serve as a predictive biomarker for response to neoadjuvant chemotherapy in locally advanced cervical cancer
    Kangni Zou et al, 2022, Frontiers in Oncology CrossRef
14. MicroRNA-326 impairs chemotherapy resistance in non small cell lung cancer by suppressing histone deacetylase SIRT1-mediated HIF1α and elevating VEGFA
    Jinying Wei et al, 2022, Bioengineered CrossRef
15. Silencing HMGN5 suppresses cell growth and promotes chemosensitivity in esophageal squamous cell carcinoma
    Xiaoping Liu et al, 2017, Journal of Biochemical and Molecular Toxicology CrossRef
16. Sevoflurane inhibits proliferation, invasion, but enhances apoptosis of lung cancer cells by Wnt/β-catenin signaling via regulating lncRNA PCAT6/ miR-326 axis
    Guoning Su et al, 2020, Open Life Sciences CrossRef
17. Overexpression of microRNA-495 suppresses the proliferation and invasion and induces the apoptosis of osteosarcoma cells by targeting high-mobility group nucleosome-binding domain 5
    Weibo Jiang et al, 2017, Oncology Reports CrossRef
18. Clinical significance of high expression of miR-452-5p in lung squamous cell carcinoma
    Xiao‑Ning Gan et al, 2018, Oncology Letters CrossRef
19. Diagnostic biomarker and therapeutic target applications of miR‐326 in cancers: A systematic review
    Golamreza Jadideslam et al, 2019, Journal of Cellular Physiology CrossRef
20. The response and resistance to drugs in ovarian cancer cell lines in 2D monolayers and 3D spheroids
    Monika Świerczewska et al, 2023, Biomedicine & Pharmacotherapy CrossRef